Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monitoring the efficacy and safety of Lantus in type 2 diabetes patients failing glycemic control with premix or NPH plus oral agents or short-acting insulin
IRCT2012110411356N1Phase 4Completed
- Sponsor
- Sanofi
- Start
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Dec 2011; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT2012110411356N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2012110411356N1.